T.J.M. de Witte

1.6k total citations
29 papers, 1.1k citations indexed

About

T.J.M. de Witte is a scholar working on Hematology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, T.J.M. de Witte has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 8 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in T.J.M. de Witte's work include Acute Myeloid Leukemia Research (15 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Acute Lymphoblastic Leukemia research (4 papers). T.J.M. de Witte is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Acute Lymphoblastic Leukemia research (4 papers). T.J.M. de Witte collaborates with scholars based in Netherlands, France and Italy. T.J.M. de Witte's co-authors include Joop H. Jansen, Bert A. van der Reijden, Nicole Blijlevens, J. Peter Donnelly, Éliane Gluckman, Volker Runde, Reinier Raymakers, Petra Muus, Marc H.G.P. Raaijmakers and Aloïs Gratwohl and has published in prestigious journals such as Blood, Clinical Cancer Research and European Journal of Cancer.

In The Last Decade

T.J.M. de Witte

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T.J.M. de Witte Netherlands	18	766	352	304	242	161	29	1.1k
Dong Soon Lee South Korea	18	575 0.8×	329 0.9×	252 0.8×	203 0.8×	100 0.6×	75	882
Hongyan Tong China	20	764 1.0×	514 1.5×	250 0.8×	225 0.9×	156 1.0×	169	1.3k
Arno Enno Australia	13	501 0.7×	279 0.8×	224 0.7×	298 1.2×	245 1.5×	24	967
M. A. Boogaerts Belgium	20	823 1.1×	266 0.8×	262 0.9×	242 1.0×	135 0.8×	29	1.2k
Harry Iland Australia	18	838 1.1×	591 1.7×	550 1.8×	260 1.1×	77 0.5×	61	1.5k
Hiroshi Tsutani Japan	16	439 0.6×	338 1.0×	127 0.4×	160 0.7×	178 1.1×	82	979
Carlos Chiattone Brazil	22	551 0.7×	171 0.5×	503 1.7×	278 1.1×	82 0.5×	99	1.1k
Muhammad Shurafa United States	12	420 0.5×	271 0.8×	262 0.9×	319 1.3×	91 0.6×	29	912
Jean‐Baptiste Micol France	18	726 0.9×	452 1.3×	306 1.0×	140 0.6×	144 0.9×	59	1.1k
James K. Mangan United States	18	514 0.7×	345 1.0×	257 0.8×	347 1.4×	123 0.8×	64	1.1k

Countries citing papers authored by T.J.M. de Witte

Since Specialization

Citations

This map shows the geographic impact of T.J.M. de Witte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.J.M. de Witte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.J.M. de Witte more than expected).

Fields of papers citing papers by T.J.M. de Witte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T.J.M. de Witte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.J.M. de Witte. The network helps show where T.J.M. de Witte may publish in the future.

Co-authorship network of co-authors of T.J.M. de Witte

This figure shows the co-authorship network connecting the top 25 collaborators of T.J.M. de Witte. A scholar is included among the top collaborators of T.J.M. de Witte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T.J.M. de Witte. T.J.M. de Witte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grand, Mia Klinten, T.J.M. de Witte, & Hein Putter. (2018). Dynamic prediction of cumulative incidence functions by direct binomial regression. Biometrical Journal. 60(4). 734–747. 5 indexed citations

Johnston, W. Thomas, Alexandra Smith, Louise de Swart, et al.. (2016). Erythropoiesis‐stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower‐risk myelodysplastic syndrome. Journal of Internal Medicine. 281(3). 284–299. 22 indexed citations

Raymakers, Reinier, et al.. (2010). Recent advances in the understanding of iron overload in sideroblastic myelodysplastic syndrome. British Journal of Haematology. 149(3). 322–333. 17 indexed citations

Pennings, Jeroen L. A., P. Linssen, Petra Muus, et al.. (2009). Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome. Blood. 114(27). 5512–5521. 83 indexed citations

Herbers, A H E, Nicole Blijlevens, J. Peter Donnelly, & T.J.M. de Witte. (2008). Bacteraemia coincides with low citrulline concentrations after high-dose melphalan in autologous HSCT recipients. Bone Marrow Transplantation. 42(5). 345–349. 46 indexed citations

Raaijmakers, Marc H.G.P., Bert A. van der Reijden, Joop H. Jansen, et al.. (2005). Impaired breast cancer resistance protein mediated drug transport in plasma cells in multiple myeloma. Leukemia Research. 29(12). 1455–1458. 22 indexed citations

Amadori, Sergio, Stefan Suciu, R. Willemze, et al.. (2004). Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups.. PubMed. 89(8). 950–6. 63 indexed citations

Land, Belinda van’t, Nicole Blijlevens, Jurgen A. Marteijn, et al.. (2003). Role of curcumin and the inhibition of NF-κB in the onset of chemotherapy-induced mucosal barrier injury. Leukemia. 18(2). 276–284. 58 indexed citations

Wittebol, Shulamiet, W.A.J.G. Lemmens, Lambertus A. Kiemeney, et al.. (2003). The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplastic syndrome patients aged less than 61 years according to International Prognostic Scoring System risk groups. British Journal of Haematology. 123(1). 81–89. 15 indexed citations

10.

Schaap, Nicolaas, et al.. (2001). Chimerism patterns in subpopulations of PBMCs in stable mixed chimeras after T-cell depleted SCT. Bone Marrow Transplantation. 27.

11.

Meer, Arnold van der, Irma Joosten, A Schattenberg, T.J.M. de Witte, & Wil A. Allebes. (2000). Cytotoxic T-lymphocyte precursor frequency (CTLp-f) as a tool for distinguishing permissible from non-permissible class I mismatches in T-cell-depleted allogeneic bone marrow transplantation. British Journal of Haematology. 111(2). 685–694. 22 indexed citations

12.

Cornelissen, Jan J., W.E. Fibbe, A Schattenberg, et al.. (1998). A retrospective Dutch study comparing T cell-depleted allogeneic blood stem cell transplantation vs T cell-depleted allogeneic bone marrow transplantation.. PubMed. 21 Suppl 3. S66–70. 11 indexed citations

13.

Croockewit, Alexandra, Miguel H. Bronchud, Matti Aapro, et al.. (1997). A European perspective on haematopoietic growth factors in haemato-oncology: Report of an expert meeting of the EORTC. European Journal of Cancer. 33(11). 1732–1746. 12 indexed citations

14.

Witte, T.J.M. de, Anja van Biezen, J. Hermans, et al.. (1997). Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. Chronic and Acute Leukemia Working Parties of the European Group for Blood and Marrow Transplantation.. Blood. 90(10). 3853–7. 82 indexed citations

15.

Witte, T.J.M. de. (1997). Allogeneic and autologous stem cell transplantation in myelodysplastic syndromes.. PubMed. 45(8). 643–9. 3 indexed citations

16.

Dolstra, Harry, E. van de Wiel-van Kemenade, T.J.M. de Witte, & Frank Preijers. (1996). Clonal predominance of cytomegalovirus-specific CD8+ cytotoxic T lymphocytes in bone marrow recipients.. PubMed. 18(2). 339–45. 24 indexed citations

17.

Suciu, Stefan, T.J.M. de Witte, Franco Mandelli, et al.. (1996). Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups.. PubMed. 17(6). 993–1001. 55 indexed citations

18.

Witte, T.J.M. de, Stefan Suciu, M. Peetermans, et al.. (1995). Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG).. PubMed. 9(11). 1805–11. 99 indexed citations

19.

Brons, Paul, Nico van der Lely, C. Haanen, et al.. (1994). Cell cycle kinetics of hematopoiesis before and after in vivo administration of GM-CSF in refractory anemia: Evidence for a shortening of the granulocyte release time. Annals of Hematology. 68(4). 175–181. 2 indexed citations

20.

Speth, P A, J.B.M. Boezeman, P. Linssen, et al.. (1988). In vivo cellular adriamycin concentrations related to growth inhibition of normal and leukemic human bone marrow cells. European Journal of Cancer and Clinical Oncology. 24(4). 667–674. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact